Luminal Breast Cancer Cryoablation

LUBRECA will evaluate the safety and efficacy of cryoablation with liquid nitrogen to treat cT1cN0 luminal breast cancer diagnosed in postmenopausal women

Trial Details

NCT ID
NCT07447414
Phase
NA
Sponsor
Lucía Graña López
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Cryoablation with liquid nitrogen (Prosense® system)
Locations (sample)
  • Lugo, Lugo, Spain|43.00992,-7.55602

Key Eligibility Criteria

  • Postmenopausal women diagnosed with invasive breast cancer by core needle biopsy or vacuum-assisted biopsy
  • Lesion ≤ 2 cm (on ultrasound and contrast enhanced mammography)
  • No axillary lymphadenopathy on ultrasound
  • No axillary lymph node involvement on ultrasound.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →